Evidence map›Paper›PMID 34371538›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2021

[Quantitative hepatitis B core antibody levels can be used as a predictive index of HBsAg clearance].

X Lin, X X Wang, A X Song, J F Lu, Y L Liu, Y Jin, Z H Cao, L N Ma, Y Y Zheng, X Y Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Safety, Tolerability and Antiviral Activity of GST-HG131 in Chronic Hepatitis B: A Randomized, Double-Blind Phase IIa Study.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

X LinFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
X X WangFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
A X SongFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
J F LuFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y L LiuFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y JinFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Z H CaoFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
L N MaFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y Y ZhengFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
X Y ChenFist Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.

Funding

Beijing Municipal Administration of Hospitals Incubating Program pX2017057Capital Health Research and Development Projects 2020-1-2181Thirteenth Five-Year Major Science and Technology Projects 2017ZX10202201, 2017ZX10201201-001-008, 2017ZX10302201-004-003, 2017ZX10202202-005-010
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B, ChronicHepatitis B Surface AntigensAlanine TransaminaseAntiviral AgentsDNA, ViralHepatitis B AntibodiesHepatitis B e AntigensHepatitis B virusHumansTreatment OutcomeAlanine TransaminaseAntiviral AgentsDNA, ViralHepatitis B AntibodiesHepatitis B e AntigensHepatitis B Surface AntigensChronic hepatitis BHBsAg clearancePredictorQuantitative level of hepatitis B core antibody

Identifiers

PMID34371538
PMCPMC12813781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.